We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Next-Generation Advanced Image Processing Improves Image Contrast During Interventional Procedures

By HospiMedica International staff writers
Posted on 06 Oct 2009
A next-generation advanced image-processing (AIP) tool improves patient care by increasing the quality, sharpness, and image contrast during interventional procedures. More...
This proprietary technology has virtually eliminated image lag, benefiting clinicians while guiding and deploying devices during fluoroscopy.

Improving the ability to provide quality patient care during interventional procedures, Toshiba Medical Systems (Tokyo, Japan) is expanding the availability of Next Generation AIP to more systems in the Toshiba InfinixTM-i product line. Toshiba presented the technology at the 2009 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, CA, USA, September 21-25, 2009.

"Next Generation AIP has made an immediate impact on patient care in facilities across the country, so we are expanding its availability to additional systems in the Infinix line,” said Robert Micer, director, X-ray vascular business unit, Toshiba. "This new processor produces better image quality, reduces background noise, and improves device and vessel visualization to allow physicians to improve workflow and provide better patient care during interventional procedures.”

Next Generation AIP additionally increases image clarity during interventional procedures to create a safer, more time-efficient exam for the patient by reducing the possibility of having to reimage the patient if the image is not clear. Next Generation AIP is especially beneficial for stent implementation, patients with rapid heart rates or small tortuous arteries, bariatric patients, and emergencies.

The technology was evaluated by Dr. Vinit Lal, interventional cardiologist, Heart Place (Dallas, TX, USA), who noted the upgraded processor has increased accuracy and improved workflow and helped ensure excellent patient care. "As the first in the country to work hands-on with Next Generation AIP, I have been extremely impressed with the images produced,” said Dr. Lal. "This upgraded processor is increasing workflow, patient throughput, and cath lab utilization, all while providing a safer exam for the patient, which is exactly what is needed in today's healthcare environment.”

The technology is available now on the Infinix-i systems with mid-and large-sized flat panel detectors, optimizing imaging for cardiac, vascular, and neuro procedures.

Related Links:

Toshiba Medical Systems



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Radiofrequency Generator
GX1
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.